AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionBrooks, Moore & Associates, Inc.
Latest Disclosed Ownership27,417 shares
Latest Disclosed Value $ 5,963,117
Brooks, Moore & Associates, Inc. reports 3.69% decrease in ownership of 4AB / AbbVie Inc.

On May 15, 2026 - Brooks, Moore & Associates, Inc. filed a 13F-HR form disclosing ownership of 27,417 shares of AbbVie Inc. (BG:4AB) valued at $5,963,117 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 28,467 shares of AbbVie Inc.. This represents a change in shares of -3.69% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBVIE COM 00287Y109 27,417 -1,050 -3.69 5,963 -8.32 2.9899
2026-02-17 2025-12-31 13F ABBVIE COM 00287Y109 28,467 175 0.62 6,505 -0.70 3.1972
2025-11-17 2025-09-30 13F ABBVIE COM 00287Y109 28,292 -200 -0.70 6,551 21.61 3.3207
2025-08-15 2025-06-30 13F ABBVIE COM 00287Y109 28,492 149 0.53 5,386 -9.30 2.9066
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 28,343 -200 -0.70 5,938 17.07 3.3495
2025-02-14 2024-12-31 13F ABBVIE COM 00287Y109 28,543 0 0.00 5,072 -10.01 2.9992
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 28,543 -153 -0.53 5,637 14.53 3.3291
2024-08-15 2024-06-30 13F ABBVIE COM 00287Y109 28,696 0 0.00 4,922 -5.82 3.1652
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 28,696 -85 -0.30 5,226 17.15 3.3518
2024-02-15 2023-12-31 13F ABBVIE COM 00287Y109 28,781 -200 -0.69 4,460 111,400.00 3.0657
2023-11-15 2023-09-30 13F ABBVIE COM 00287Y109 28,981 -1,349 -4.45 4 0.00 3.2619
2023-08-15 2023-06-30 13F ABBVIE COM 00287Y109 30,330 -488 -1.58 4 0.00 2.8762
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 30,818 585 1.93 5 0.00 3.5276
2023-02-03 2022-12-31 13F ABBVIE COM 00287Y109 30,233 -6,713 -18.17 5 -99.92 3.5690
2022-11-17 2022-09-30 13F ABBVIE COM 00287Y109 36,946 892 2.47 4,959 -10.20 4.0114
2022-08-04 2022-06-30 13F ABBVIE COM 00287Y109 36,054 -1,534 -4.08 5,522 -9.37 3.9813
2022-05-03 2022-03-31 13F ABBVIE COM 00287Y109 37,588 -2,800 -6.93 6,093 11.41 3.7402
2022-02-04 2021-12-31 13F ABBVIE COM 00287Y109 40,388 1,060 2.70 5,469 28.93 3.2079
2021-11-08 2021-09-30 13F ABBVIE COM 00287Y109 39,328 -4,645 -10.56 4,242 -14.35 2.7756
2021-07-21 2021-06-30 13F ABBVIE COM 00287Y109 43,973 -375 -0.85 4,953 3.21 3.1598
2021-05-04 2021-03-31 13F ABBVIE COM 00287Y109 44,348 2,375 5.66 4,799 6.72 3.2519
2021-02-08 2020-12-31 13F ABBVIE COM 00287Y109 41,973 2,066 5.18 4,497 28.63 3.4839
2020-11-02 2020-09-30 13F ABBVIE COM 00287Y109 39,907 6,719 20.25 3,496 7.31 3.0143
2020-08-10 2020-06-30 13F ABBVIE COM 00287Y109 33,188 2,371 7.69 3,258 38.76 3.0504
2020-04-22 2020-03-31 13F ABBVIE COM 00287Y109 30,817 2,110 7.35 2,348 -7.63 2.4944
2020-01-30 2019-12-31 13F ABBVIE COM 00287Y109 28,707 1 0.00 2,542 16.93 2.0162
2019-11-06 2019-09-30 13F/A-1 ABBVIE COM 00287Y109 28,706 7,924 38.13 2,174 43.88 1.8364
2019-10-25 2019-09-30 13F ABBVIE COM 00287Y109 28,706 7,924 2,174 1,836,412.3227
2019-08-09 2019-06-30 13F ABBVIE COM 00287Y109 20,782 3,175 18.03 1,511 6.48 1.2979
2019-04-24 2019-03-31 13F ABBVIE COM 00287Y109 17,607 1,200 7.31 1,419 -6.21 1.2948
2019-02-06 2018-12-31 13F ABBVIE COM 00287Y109 16,407 16,407 1,513 1.5231
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.